Clinical Trials Logo
  1. Home
  2. Atrophic Vaginitis
  3. NCT02995694

A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis

Atrophic Vaginitis Clinical Trial

Official title:
Clinical Endpoint Therapeutic Equivalence Multi-Site Study Comparing Estradiol Vaginal Cream (0.01%; Alvogen Pine Brook LLC.) to Estrace® Cream (0.01%; Warner Chilcott) in Postmenopausal Females With Atrophic Vaginitis

Clinical Trial Summary

The purpose of this study is to determine the therapeutic equivalence of Alvogen's estradiol vaginal cream to Estrace® cream and superiority of both products to placebo. The protocol describes a randomized, double-blind, multi-dose, placebo-controlled, parallel study of a 7 day treatment.

Clinical Trial Description

This randomized, double-blind, placebo-controlled, parallel group, multiple-site study was designed to evaluate the therapeutic efficacy and safety of a generic Estradiol Vaginal Cream USP, 0.01% (Alvogen Pine Brook LLC) compared to the FDA Reference Listed Drug (RLD), Estrace® (estradiol vaginal cream USP, 0.01%, Warner Chilcott) in patients with atrophic vaginitis. Additionally, both the Test and the RLD formulations were tested for superiority against a Placebo. Following the 14-day screening period, patients who continued to meet the inclusion/exclusion criteria were randomized in a 2:2:1 ratio (Test: Reference: Placebo) for 7 days of treatment. Five hundred and thirty-five (535) patients were randomized to one of the three study products as follows: - Test: Estradiol Vaginal Cream USP, 0.01% (Alvogen Pine Brook LLC) - Reference: Estrace® (estradiol vaginal cream USP, 0.01%) (Warner Chilcott) - Placebo: Test product vehicle cream (Alvogen Pine Brook LLC) Patients completed up to three clinic visits as follows: - Visit 1 - Screening: Day -14 to Day -1 - Visit 2 - Randomization: Day 1 - Visit 3 - End of Study: Day 8, maximum Day 10 Study product was self-administered by the patient for 7 days according to the dosing instructions provided. Each patient was required to dose once daily at approximately the me of day for 7 consecutive days. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02995694
Study type Interventional
Source Alvogen Pine Brook LLC
Contact
Status Completed
Phase Phase 3
Start date March 2016
Completion date December 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT00984399 - Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen N/A
Completed NCT04079218 - Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial Phase 4
Recruiting NCT05953090 - VALOR: Vaginal Atrophy & Long-term Observation of Recovery N/A
Terminated NCT00816556 - A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis Phase 3
Completed NCT00167921 - Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis Phase 1
Completed NCT04327947 - Evaluation of Gynecological Acceptability of 3 Health Care Products N/A
Recruiting NCT05118685 - Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis Phase 1
Completed NCT03294538 - Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis Phase 3
Completed NCT05058313 - Evaluation of the Safety and Performance of the MILTA GYNECO Vaginal Probe in Postmenopausal Women With Vaginal Atrophy N/A
Completed NCT02691936 - Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy N/A
Recruiting NCT06305494 - Genitourinary Syndrome of Menopause in Thai Gynecologic Cancer Survivors
Completed NCT02195986 - A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis Phase 3
Recruiting NCT03981458 - Hyaluronate for the Treatment and Prevention of Recurrent Urinary Tract Infection in Women Suffering Atrophic Vaginitis N/A
Completed NCT05396261 - a Flexible Wound Dressing for the Management of Genital Skin Conditions N/A
Completed NCT02869165 - Vaginal and Urinary Microbiome Trial Phase 4
Completed NCT02029053 - Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness Phase 0
Not yet recruiting NCT06176820 - Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause Phase 2/Phase 3
Recruiting NCT02733731 - The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis Phase 1
Withdrawn NCT02460302 - Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy Phase 2
Completed NCT02313545 - Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIV Phase 1/Phase 2